Sulfabid (sulfaphenazole) is a small molecule pharmaceutical. Sulfaphenazole was first approved as Sulfabid on 1982-01-01. It is known to target cytochrome P450 2C9.
Trade Name |
Sulfabid |
Common Name |
Sulfaphenazole |
Indication |
|
Drug Class |
Antimicrobials (sulfonamides derivatives) |